Sarfez Pharmaceuticals, Inc. is a Virginia company focused on improving existing drugs using proprietary extended release formulation technology, repurposing ...
Fatima Khwaja Chief Executive Officer. Dr. Khwaja has more than 20 years of experience in drug development and has been involved in drug repurposing ...
Get information, directions, products, services, phone numbers, and reviews on Sarfez Pharmaceuticals in Vienna, VA. Discover more Pharmaceutical ...
Affichem USA Inc. CEO. AFII, Director - Healthcare & agribusiness. AIG, Vice President, Global Health Product Development and Design. Aisling Capital, Partner.
Awards Year: 2016. Solitcitation Year: 2016. Solitcitation Topic Code: NHLBI. Solitcitation Number: PA15-269. Small Business Information. SARFEZ USA, INC.
Sarfez Pharmaceuticals is developing an extended release formulation of ... The company anticipates that the data from this trial will provide the basis for the NDA submission with the US FDA. ... Sarfez Pharmaceuticals, Originator, USA.
Sarfez USA, Inc., Vienna, VA, United States ... cardiovascular disease (ASCVD) is the leading cause of death and disability for men and women in the USA.
DK Diagnostics USA, Hagerstown, MD, Diagnostics. Add'l Locations ... Sarfez Pharmaceuticals, Rockville, MD, Extended release formulation technology.
Apr 18, 2017 ... (6)Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. (7)AP-HP ... ( 26)Sarfez Pharmaceuticals, Inc., McLean, VA, USA. (27)ZS ...